New UK analysis declares reduced severity of Omicron variant of COVID-19


On Friday, researchers in the UK reported that the Omicron variant of SARS-COV-2 (COVID-19) has a lower risk of hospitalisation and a shorter duration in the vaccinated population than previous variants, including Delta.

King’s College London and ZOE COVID Study scientists studied the symptoms of 62,002 vaccinated individuals to conclude that those infected with Omicron are more likely to have a sore throat and less likely to experience loss of smell compared to Delta.


The findings, published in ‘The Lancet’ this week, show the duration of symptoms were also significantly shorter for Omicron compared to the Delta variant – 6.87 days versus 8.89 days, respectively – and participants were less likely to be hospitalised.

“Although there is still a wide range of duration and severity of symptoms with Omicron, for vaccinated individuals, we find on average a shorter duration of symptoms. This suggests that the incubation time and period of infectiousness for Omicron may also be shorter,” said Professor Ana Valdes, Honorary Professor at King’s College London.

The researchers note that symptoms associated with an Omicron infection have less involvement of the lungs and do not last as long in vaccinated people.

The most striking difference between variants was the difference in loss of sense of smell, a common symptom of earlier variants – appearing in 52.7 per cent of Delta cases, only arising in under 20 per cent of Omicron cases and often days later.

The two symptoms that were consistently more prevalent among Omicron than Delta cases, regardless of vaccination status, were a sore throat and hoarse voice. Moreover, many debilitating symptoms, such as brain fog, eye burning, dizziness, fever, and headaches, though still occurring, were all significantly less prevalent in Omicron cases.

The UK’s National Health Service (NHS) had added further symptoms to watch out for, including shortness of breath; feeling tired or exhausted; aching body; headache; sore throat; blocked or runny nose; loss of appetite; diarrhoea; and feeling sick or being sick


Share post:



More like this

India and Japan Have Completed “Veer Guardian 2023.”

On January 26, 2023, the first edition of the bilateral air exercise "Veer Guardian 2023" between the IAF and the JASDF was completed in Japan.

A Glimpse into the Future: The World of 2100

The world's population will have risen to roughly 10 billion, with the majority of people living in cities.

President El-Sisi India Visit: Step Towards Strengthening Relations

Narendra Modi and Abdel Fattah El-Sisi attended the "At Home" reception at the Rashtrapati Bhawan, and El-Sisi served as the chief guest.

Major Western Powers Send Tanks to Ukraine in Show of Support

Olaf Schultz, the chancellor of Germany, recently declared that Germany would send 14 Leopard tanks to Ukraine.